Blood-brain barrier permeability study of ginger constituents

Alexandra Simon, András Darcsi, A. Kéry, Eszter Riethmüller

Research output: Article

Abstract

Ginger, the rhizome of Zingiber officinale Roscoe is of great importance in the traditional medicine for the treatment of various diseases. More than 400 constituents have been reported in the plant, the most important ones being the gingerol and shogaol derivatives. Positive effects of ginger extracts and isolated [6]-gingerol have been proved in animal models of anxiety, Alzheimer's disease, Parkinson's disease and epilepsy. Taken in consideration these promising positive effects of ginger and its constituents in the central nervous system, the isolation of gingerol and shogaol derivatives ([6]-gingerol (1), [8]-gingerol (2), [10]-gingerol (3), [6]-shogaol (4), [10]-shogaol (5), 1-dehydro-[6]-gingerdione (6), 1-dehydro-[10]-gingerdione (7)) and investigation of their transcellular passive diffusion across the blood-brain barrier (BBB) were carried out. For this purpose, a Parallel Artificial Membrane Permeability Assay for the Blood-Brain Barrier (PAMPA-BBB) was chosen that had previously been validated for natural compounds. Based on our results, [6]-gingerol, [8]-gingerol and [6]-shogaol were found to be able to penetrate the BBB via passive diffusion, suggesting them to contribute to the positive effects of ginger extracts in the central nervous system.

Original languageEnglish
Article number112820
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume177
DOIs
Publication statusPublished - jan. 5 2020

Fingerprint

Ginger
Blood-Brain Barrier
Permeability
Neurology
Central Nervous System
Derivatives
Artificial Membranes
Rhizome
Traditional Medicine
Medicine
Parkinson Disease
gingerol
shogaol
Epilepsy
Assays
Alzheimer Disease
Animals
Anxiety
Animal Models
Membranes

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmaceutical Science
  • Drug Discovery
  • Spectroscopy
  • Clinical Biochemistry

Cite this

Blood-brain barrier permeability study of ginger constituents. / Simon, Alexandra; Darcsi, András; Kéry, A.; Riethmüller, Eszter.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 177, 112820, 05.01.2020.

Research output: Article

Simon, Alexandra ; Darcsi, András ; Kéry, A. ; Riethmüller, Eszter. / Blood-brain barrier permeability study of ginger constituents. In: Journal of Pharmaceutical and Biomedical Analysis. 2020 ; Vol. 177.
@article{673461c1ee07498a8567bbbc2363f4ee,
title = "Blood-brain barrier permeability study of ginger constituents",
abstract = "Ginger, the rhizome of Zingiber officinale Roscoe is of great importance in the traditional medicine for the treatment of various diseases. More than 400 constituents have been reported in the plant, the most important ones being the gingerol and shogaol derivatives. Positive effects of ginger extracts and isolated [6]-gingerol have been proved in animal models of anxiety, Alzheimer's disease, Parkinson's disease and epilepsy. Taken in consideration these promising positive effects of ginger and its constituents in the central nervous system, the isolation of gingerol and shogaol derivatives ([6]-gingerol (1), [8]-gingerol (2), [10]-gingerol (3), [6]-shogaol (4), [10]-shogaol (5), 1-dehydro-[6]-gingerdione (6), 1-dehydro-[10]-gingerdione (7)) and investigation of their transcellular passive diffusion across the blood-brain barrier (BBB) were carried out. For this purpose, a Parallel Artificial Membrane Permeability Assay for the Blood-Brain Barrier (PAMPA-BBB) was chosen that had previously been validated for natural compounds. Based on our results, [6]-gingerol, [8]-gingerol and [6]-shogaol were found to be able to penetrate the BBB via passive diffusion, suggesting them to contribute to the positive effects of ginger extracts in the central nervous system.",
keywords = "Blood-brain barrier, Ginger, Gingerol, PAMPA-BBB, Shogaol, Zingiber officinale",
author = "Alexandra Simon and Andr{\'a}s Darcsi and A. K{\'e}ry and Eszter Riethm{\"u}ller",
year = "2020",
month = "1",
day = "5",
doi = "10.1016/j.jpba.2019.112820",
language = "English",
volume = "177",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",

}

TY - JOUR

T1 - Blood-brain barrier permeability study of ginger constituents

AU - Simon, Alexandra

AU - Darcsi, András

AU - Kéry, A.

AU - Riethmüller, Eszter

PY - 2020/1/5

Y1 - 2020/1/5

N2 - Ginger, the rhizome of Zingiber officinale Roscoe is of great importance in the traditional medicine for the treatment of various diseases. More than 400 constituents have been reported in the plant, the most important ones being the gingerol and shogaol derivatives. Positive effects of ginger extracts and isolated [6]-gingerol have been proved in animal models of anxiety, Alzheimer's disease, Parkinson's disease and epilepsy. Taken in consideration these promising positive effects of ginger and its constituents in the central nervous system, the isolation of gingerol and shogaol derivatives ([6]-gingerol (1), [8]-gingerol (2), [10]-gingerol (3), [6]-shogaol (4), [10]-shogaol (5), 1-dehydro-[6]-gingerdione (6), 1-dehydro-[10]-gingerdione (7)) and investigation of their transcellular passive diffusion across the blood-brain barrier (BBB) were carried out. For this purpose, a Parallel Artificial Membrane Permeability Assay for the Blood-Brain Barrier (PAMPA-BBB) was chosen that had previously been validated for natural compounds. Based on our results, [6]-gingerol, [8]-gingerol and [6]-shogaol were found to be able to penetrate the BBB via passive diffusion, suggesting them to contribute to the positive effects of ginger extracts in the central nervous system.

AB - Ginger, the rhizome of Zingiber officinale Roscoe is of great importance in the traditional medicine for the treatment of various diseases. More than 400 constituents have been reported in the plant, the most important ones being the gingerol and shogaol derivatives. Positive effects of ginger extracts and isolated [6]-gingerol have been proved in animal models of anxiety, Alzheimer's disease, Parkinson's disease and epilepsy. Taken in consideration these promising positive effects of ginger and its constituents in the central nervous system, the isolation of gingerol and shogaol derivatives ([6]-gingerol (1), [8]-gingerol (2), [10]-gingerol (3), [6]-shogaol (4), [10]-shogaol (5), 1-dehydro-[6]-gingerdione (6), 1-dehydro-[10]-gingerdione (7)) and investigation of their transcellular passive diffusion across the blood-brain barrier (BBB) were carried out. For this purpose, a Parallel Artificial Membrane Permeability Assay for the Blood-Brain Barrier (PAMPA-BBB) was chosen that had previously been validated for natural compounds. Based on our results, [6]-gingerol, [8]-gingerol and [6]-shogaol were found to be able to penetrate the BBB via passive diffusion, suggesting them to contribute to the positive effects of ginger extracts in the central nervous system.

KW - Blood-brain barrier

KW - Ginger

KW - Gingerol

KW - PAMPA-BBB

KW - Shogaol

KW - Zingiber officinale

UR - http://www.scopus.com/inward/record.url?scp=85071464219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071464219&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2019.112820

DO - 10.1016/j.jpba.2019.112820

M3 - Article

AN - SCOPUS:85071464219

VL - 177

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

M1 - 112820

ER -